ARTERRA BIOSCIENCE (ARBS.MI)

EUR 2.36

(-0.84%)

Total Liabilities Summary of ARTERRA BIOSCIENCE

  • ARTERRA BIOSCIENCE's latest annual total liabilities in 2023 was 1.8 Million EUR , down -14.26% from previous year.
  • ARTERRA BIOSCIENCE's latest quarterly total liabilities in 2024 Q2 was 1.93 Million EUR , down 0.0% from previous quarter.
  • ARTERRA BIOSCIENCE reported annual total liabilities of 2.1 Million EUR in 2022, down -0.38% from previous year.
  • ARTERRA BIOSCIENCE reported annual total liabilities of 2.11 Million EUR in 2021, down -1.55% from previous year.
  • ARTERRA BIOSCIENCE reported quarterly total liabilities of 1.8 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • ARTERRA BIOSCIENCE reported quarterly total liabilities of 2.32 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of ARTERRA BIOSCIENCE (2023 - 2017)

Historical Annual Total Liabilities of ARTERRA BIOSCIENCE (2023 - 2017)

Year Total Liabilities Total Liabilities Growth
2023 1.8 Million EUR -14.26%
2022 2.1 Million EUR -0.38%
2021 2.11 Million EUR -1.55%
2020 2.14 Million EUR -12.29%
2019 2.44 Million EUR 10.11%
2018 2.21 Million EUR 26.25%
2017 1.75 Million EUR 0.0%

Peer Total Liabilities Comparison of ARTERRA BIOSCIENCE

Name Total Liabilities Total Liabilities Difference
Philogen S.p.A. 28.68 Million EUR 93.716%
Ulisse Biomed S.p.A. 4.69 Million EUR 61.628%